Hepatitis G virus infection in patients with hepatitis C virus infection undergoing liver transplantation

M Berenguer1, N A Terrault, M Piatak

  • 1Department of Medicine, Department of Veterans Affairs Medical Center, San Francisco, California, USA.

Gastroenterology
|December 1, 1996
PubMed

Insights

Hepatitis G virus (HGV) coinfection is common in liver transplant patients with hepatitis C virus (HCV). However, HGV coinfection does not impact liver disease severity or survival post-transplantation.

Area of Science:

  • Hepatology
  • Virology
  • Transplantation Medicine

Background:

  • Hepatitis G virus (HGV) transmission via blood transfusion is known, but its impact on chronic liver disease remains unclear.
  • The study investigates the role of HGV in patients with hepatitis C virus (HCV) undergoing liver transplantation.

Purpose of the Study:

  • Determine HGV prevalence in HCV patients awaiting liver transplantation.
  • Evaluate the effect of HGV coinfection on post-transplantation HCV outcomes.

Main Methods:

  • Serum samples from 124 HCV patients undergoing liver transplantation were analyzed for HCV and HGV RNA.
  • HCV RNA levels were quantified using branched DNA assay, and HCV genotyping was performed.

Main Results:

  • Prevalence of HGV infection was 24% before and 28% after transplantation.
  • HGV coinfection did not significantly alter post-transplantation HCV RNA levels or disease severity.
  • HCV genotype 1b was more common in coinfected patients, but graft and patient survival were unaffected.

Conclusions:

  • HGV coinfection is frequent in end-stage HCV patients undergoing liver transplantation.
  • No association found between HGV coinfection and post-transplantation liver disease severity, graft, or patient survival.
Abstract

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...